Delivery Order SPE2D021D0003-SPE2D325F341V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Levofloxacin 25 mg/ml Solution in 480 ml quantities, with a ceiling value of $3,960.98 and an ultimate completion date of September 2, 2025. This is a firm fixed price delivery order with no set-aside designation, executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical...
- The Defense Logistics Agency awarded a $229,880 firm fixed price delivery order to Amerisourcebergen Drug Corporation for levofloxacin injection. The contract calls for the delivery of 4561599053 units of levofloxacin 500 mg/100 ml in D5W 100ml bags to a location in Conshohocken, Pennsylvania by July 26, 2023. As a major provider of medical supplies and pharmaceuticals to the Department of Defense, this order for the antibiotic levofloxacin supports the DLA's mission to provide critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 29, 2025, for the supply of Levofloxacin 25 mg/ml Solution in 480ml quantities, with a ceiling value of $3,473.14. This is a firm fixed-price, competitive award with no set-aside designation and an ultimate completion date of July 30, 2025. The contract is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at...
- The Defense Logistics Agency awarded a $464 firm fixed price delivery order to Amerisourcebergen Drug Corporation for levofloxacin injection. The order is for 4562053796 units of 750 mg/150 ml levofloxacin in 150 ml bags for intravenous infusion. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania over one day in September 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and supply chain to support the...
- The Defense Logistics Agency Troop Support Medical awarded a $54,070 delivery order to DMS Pharmaceutical Group Inc. to supply 750 mg/150 ml vials of the antibiotic levofloxacin under national stock number (NSN) 4561408497. Performance will take place in Park Ridge, Illinois over one day in July 2023. The firm fixed price order was issued against an existing DLA pharmaceuticals contract vehicle and supports the agency's mission to provide quality medical supplies to all branches of the U.S....
- The Defense Logistics Agency Troop Support Medical awarded a $54,070 firm fixed price delivery order to DMS Pharmaceutical Group Inc. to supply 750 mg/150 ml vials of the antibiotic levofloxacin under National Stock Number 6505-01-452-2028. Performance will take place in Park Ridge, Illinois over a four day period from September 1-5, 2023. The contract was awarded using the prime vendor indefinite-delivery/indefinite-quantity multiple award schedule managed by DLA Troop Support Medical to...
- This delivery order for $54 worth of levofloxacin solution was awarded by the Defense Logistics Agency to DMS Pharmaceutical Group Inc. of Park Ridge, Illinois. The contract calls for DMS Pharmaceutical Group to provide 4559950913 units of levofloxacin 750 mg/150 ml in D5W 150ml solution by February 6, 2023. The firm fixed price order was awarded on February 3 without a set-aside designation. DMS Pharmaceutical Group will deliver the generic antibiotic intravenous solution to an unspecified...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $86,610 to DMS Pharmaceutical Group Inc. to supply 750 mg/150 ml vials of the antibiotic levofloxacin under national stock number (NSN) 4562387893. Performance will take place in Park Ridge, Illinois over a four-day period concluding on August 29, 2023. The contract was awarded utilizing the prime vendor indefinite-delivery/indefinite-quantity (IDIQ) pharmaceutical contract to fulfill ongoing...
- The Defense Logistics Agency awarded a $466 delivery order to Amerisourcebergen Drug Corporation for levofloxacin injection. The firm fixed price order is for 100mL of levofloxacin 500 mg/100 mL solution to be delivered from Amerisourcebergen's facility in Conshohocken, Pennsylvania to an unspecified location. Performance will take place from July 5-6, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for an antibiotic injection...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at fifty-four thousand seven dollars to DMS Pharmaceutical Group Incorporated. The order is for one hundred fifty milliliters of the pharmaceutical levofloxacin to be delivered to a facility in Park Ridge, Illinois. Performance will take place between July 10th and 11th, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics network and supply chain, and this order...
- SPE2D021D0003Indefinite Delivery Contract
- SPE2D021D0003-SPE2D325F341VDelivery Order
The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $4,623.00 to Sagent Pharmaceuticals, Inc. for the supply of Levofloxacin 750 mg/150 mL in dextrose 5% water (D5W) solution. This firm fixed-price delivery order, effective through August 28, 2025, was awarded on August 28, 2025, without a set-aside designation, indicating the award was competed on an unrestricted basis. The product will be delivered to Schaumburg, Illinois, where Sagent Pharmaceuticals maintains its headquarters and primary manufacturing operations. Levofloxacin is a broad-spectrum fluoroquinolone antibiotic commonly used in military and federal healthcare settings for treating bacterial infections in acute care environments. This delivery order is issued under Sagent Pharmaceuticals' larger $29.6 million indefinite delivery/indefinite quantity contract with the Defense Logistics Agency Troop Support Medical, which runs through March 3, 2031. As a specialty pharmaceutical manufacturer specializing in injectable products, Sagent Pharmaceuticals has been a consistent supplier to federal defense and health programs since its registration in the System for Award Management in 2007. The company's contract portfolio demonstrates its capability to fulfill both routine pharmaceutical supply requirements and large-scale federal medical logistics needs across multiple therapeutic categories for military treatment facilities and other federal healthcare institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.6k | 8/25/25 |